Fig. 5From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validationThe Kaplan–Meier survival curves for TSPOAP1, ADGRG6, GPR87, FAM111B and MMP28 in the low- and high- risk groups. These 5 genes can significantly differentiate the survival time of PC patients (Log-rank test P < 0.0001)Back to article page